Bone marrow-derived progenitors are greatly reduced in patients with severe COPD and low-BMI

[1]  E. Benjamin,et al.  Systemic inflammation and COPD: the Framingham Heart Study. , 2008, Chest.

[2]  M. Charbonneau,et al.  Hypoxia-inducible Factor Mediates Hypoxic and Tumor Necrosis Factor α-induced Increases in Tumor Necrosis Factor-α Converting Enzyme/ADAM17 Expression by Synovial Cells* , 2007, Journal of Biological Chemistry.

[3]  E. Feigl,et al.  Fibroblast growth factor-2 regulates myocardial infarct repair: effects on cell proliferation, scar contraction, and ventricular function. , 2007, The American journal of pathology.

[4]  A. Avogaro,et al.  Critical assessment of putative endothelial progenitor phenotypes. , 2007, Experimental hematology.

[5]  R. Garrod,et al.  The relationship between inflammatory markers and disability in chronic obstructive pulmonary disease (COPD). , 2007, Primary care respiratory journal : journal of the General Practice Airways Group.

[6]  A. Shamseddine,et al.  Vascular endothelial growth factor family of ligands and receptors: review. , 2007, Blood cells, molecules & diseases.

[7]  J. Prchal,et al.  Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. , 2007, Blood.

[8]  B. Celli,et al.  Systemic cytokines, clinical and physiological changes in patients hospitalized for exacerbation of COPD. , 2007, Chest.

[9]  H. Augustin,et al.  Angiopoietins: a link between angiogenesis and inflammation. , 2006, Trends in immunology.

[10]  P. Laveneziana,et al.  Physiology and consequences of lung hyperinflation in COPD , 2006, European Respiratory Review.

[11]  R. Homer,et al.  Hyperoxia causes angiopoietin 2–mediated acute lung injury and necrotic cell death , 2006, Nature Medicine.

[12]  A. Zeiher,et al.  Transcoronary transplantation of progenitor cells after myocardial infarction. , 2006, The New England journal of medicine.

[13]  A. Blann,et al.  Circulating endothelial cells and endothelial progenitor cells: two sides of the same coin, or two different coins? , 2006, Atherosclerosis.

[14]  Hae-Young Lee,et al.  Differential Effect of Intracoronary Infusion of Mobilized Peripheral Blood Stem Cells by Granulocyte Colony–Stimulating Factor on Left Ventricular Function and Remodeling in Patients With Acute Myocardial Infarction Versus Old Myocardial Infarction: The MAGIC Cell-3-DES Randomized, Controlled Trial , 2006, Circulation.

[15]  A. Avogaro,et al.  Circulating Progenitor Cells Are Reduced in Patients with Severe Lung Disease , 2006, Stem cells.

[16]  L. Fabbri,et al.  Upregulation of basic fibroblast growth factor in smokers with chronic bronchitis , 2006, European Respiratory Journal.

[17]  P. Palange,et al.  Circulating haemopoietic and endothelial progenitor cells are decreased in COPD , 2006, European Respiratory Journal.

[18]  H. Augustin,et al.  Angiopoietin-2 sensitizes endothelial cells to TNF-α and has a crucial role in the induction of inflammation , 2006, Nature Medicine.

[19]  D. Sin,et al.  Skeletal muscle weakness, reduced exercise tolerance, and COPD: is systemic inflammation the missing link? , 2005, Thorax.

[20]  E. Wouters,et al.  Raised CRP levels mark metabolic and functional impairment in advanced COPD , 2005, Thorax.

[21]  E. Wouters,et al.  Muscle wasting and impaired muscle regeneration in a murine model of chronic pulmonary inflammation. , 2006, American journal of respiratory cell and molecular biology.

[22]  C. Nienaber,et al.  Preservation From Left Ventricular Remodeling by Front-Integrated Revascularization and Stem Cell Liberation in Evolving Acute Myocardial Infarction by Use of Granulocyte-Colony–Stimulating Factor (FIRSTLINE-AMI) , 2005, Circulation.

[23]  P. Sterk,et al.  Chronic obstructive pulmonary disease is associated with enhanced bronchial expression of FGF‐1, FGF‐2, and FGFR‐1 , 2005, The Journal of pathology.

[24]  Seppo Ylä-Herttuala,et al.  Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation. , 2005, The Journal of clinical investigation.

[25]  G. Nowak,et al.  Expression of Vascular Endothelial Growth Factor Receptor-2 or Tie-2 on Peripheral Blood Cells Defines Functionally Competent Cell Populations Capable of Reendothelialization , 2004, Circulation.

[26]  R. Ferrari,et al.  CD34+ and Endothelial Progenitor Cells in Patients With Various Degrees of Congestive Heart Failure , 2004, Circulation.

[27]  A Senthilselvan,et al.  Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis , 2004, Thorax.

[28]  X. Busquets,et al.  NF-κB activation and iNOS upregulation in skeletal muscle of patients with COPD and low body weight , 2004, Thorax.

[29]  Ciro Casanova,et al.  The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. , 2004, The New England journal of medicine.

[30]  Don D. Sin,et al.  Why Are Patients With Chronic Obstructive Pulmonary Disease at Increased Risk of Cardiovascular Diseases?: The Potential Role of Systemic Inflammation in Chronic Obstructive Pulmonary Disease , 2003 .

[31]  L. Fabbri,et al.  Predominant emphysema phenotype in chronic obstructive pulmonary disease patients , 2003, European Respiratory Journal.

[32]  X. Busquets,et al.  Systemic effects of chronic obstructive pulmonary disease , 2003, European Respiratory Journal.

[33]  Helen M. Blau,et al.  Biological Progression from Adult Bone Marrow to Mononucleate Muscle Stem Cell to Multinucleate Muscle Fiber in Response to Injury , 2002, Cell.

[34]  U. Testa,et al.  Circulating hematopoietic progenitor cells in runners. , 2002, Journal of applied physiology.

[35]  X. Busquets,et al.  Skeletal muscle apoptosis and weight loss in chronic obstructive pulmonary disease. , 2002, American journal of respiratory and critical care medicine.

[36]  A. Schols,et al.  Systemic effects in COPD. , 2002, Chest.

[37]  D. Biskobing.  COPD and osteoporosis. , 2002, Chest.

[38]  B. Brüne,et al.  Regulation of the Hypoxia-inducible Factor 1α by the Inflammatory Mediators Nitric Oxide and Tumor Necrosis Factor-α in Contrast to Desferroxamine and Phenylarsine Oxide* , 2001, The Journal of Biological Chemistry.

[39]  S. Fichtlscherer,et al.  Number and Migratory Activity of Circulating Endothelial Progenitor Cells Inversely Correlate With Risk Factors for Coronary Artery Disease , 2001, Circulation research.

[40]  S. Homma,et al.  Neovascularization of ischemic myocardium by human bone-marrow–derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function , 2001, Nature Medicine.

[41]  J. Hogg,et al.  The effect of repeated exposure to particulate air pollution (PM10) on the bone marrow. , 2001, American journal of respiratory and critical care medicine.

[42]  J. Hogg,et al.  The response of human bone marrow to chronic cigarette smoking. , 2000, The European respiratory journal.

[43]  P. Palange,et al.  Ventilatory and metabolic adaptations to walking and cycling in patients with COPD. , 2000, Journal of applied physiology.

[44]  W. Jelkmann,et al.  Interleukin-1β and Tumor Necrosis Factor- Stimulate DNA Binding of Hypoxia-Inducible Factor-1 , 1999 .

[45]  P. Palange,et al.  Effect of reduced body weight on muscle aerobic capacity in patients with COPD. , 1998, Chest.

[46]  E. Wouters,et al.  Weight Loss Is a Reversible Factor in the Prognosis of Chronic Obstructive Pulmonary Disease , 1998 .

[47]  P. Palange,et al.  Nutritional state and exercise tolerance in patients with COPD. , 1996, Chest.

[48]  R. Hoffman,et al.  The in vitro and in vivo effects of stem cell factor on human hematopoiesis , 1993, Stem cells.

[49]  L. Naldini,et al.  Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth , 1992, The Journal of cell biology.

[50]  J. Durnin,et al.  Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 Years , 1974, British Journal of Nutrition.

[51]  C M Fletcher,et al.  The emphysematous and bronchial types of chronic airways obstruction. A clinicopathological study of patients in London and Chicago. , 1966, Lancet.